从美国 FDA 加速途径退出的药物在中国的监管现状 : 对全球监管的影响。
Mesh : United States Food and Drug Administration / legislation & jurisprudence United States China Humans Safety-Based Drug Withdrawals Drug Approval / legislation & jurisprudence
来 源: DOI:10.1016/S1470-2045(24)00025-1